News Alert

340B Arises Briefly in Much-Anticipated Senate Hearing on High Prescription Drug Prices

Joaquin Duato, CEO of J&J, said 340B "is an important program" in response to questioning from Sen. Roger Marshall (R-Kan.).
One influential Republican senator criticized 340B and another Republican senator expressed support for the program during today’s much-awaited Senate committee [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Maryland Bills Introduced to Bar 340B Contract Pharmacy Restrictions

Maryland state Sen. Clarence Lam (D) sponsored one of two bills introduced to prohibit drugmaker 340B contract pharmacy restrictions in the state.
Maryland lawmakers in the state house and senate have introduced companion bills that would prohibit drugmaker 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Urge Supreme Court to Review DSH Payment Case with 340B Implications

The Supreme Court of the United States building
Major hospital groups have asked the Supreme Court to review a case that challenges HHS' DSH payment formula.
Major hospital groups last week urged the U.S. Supreme Court to review a federal appeals court decision that upheld how [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Multiple Bills Introduced in Missouri to Protect 340B Providers from Alleged Discriminatory Practices

The Missouri state senate recently passed a 340B contract pharmacy access bill.

Missouri state senators in recent weeks have introduced three bills with provisions to bar pharmacy benefit managers (PBMs) from what 340B providers describe as underpayments and other discriminatory practices.

On Jan. 3, Missouri state Sens. Curtis Trent (R) and Doug

Read More »

Federal Judge Rules for Diabetes Drugmakers in 340B Antitrust Case, Health Center Plans Appeal

Mosaic Health plans to appeal a federal district judge's ruling against the health center's 340B antitrust case against four diabetes drugmakers.
A federal district judge last week denied two community health centers’ antitrust claims against four major diabetes drug manufacturers over [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mississippi Bill Introduced to Bar 340B Contract Pharmacy Restrictions, PBM Underpayments

Mississippi state Sen. Brice Wiggins (R) introduced one of two bills designed to protect 340B contract pharmacy use and bar PBM 340B underpayments in the state.
Eight Mississippi state senators have introduced a bill to bar drugmakers from restricting 340B contract pharmacy use and pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Reaches $2.1 Million Settlement Over Alleged 340B Overbilling

After self-reporting an internal audit, Calif.-based Pomona Valley Medical Center reached a $2.1 million settlement to resolve allegations of 340B overbilling.
A California hospital last week reached a settlement to pay the state of California and the U.S. government a combined [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Ruling Creates Legal, Regulatory Uncertainty for 340B, Says Attorney Panel

Maureen Testoni, president and CEO of 340B Health, Jason Reddish, a principal at Powers Law, and Ross Margulies, a partner at Foley Hoag, discussed the looming uncertainty in 340B following a key federal district court ruling during the 340B Coalition Winter Conference.
A recent federal district court ruling on the 340B patient definition created a “gray area” for 340B providers and drugmakers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Potential Senate Flip May Increase 340B Scrutiny, But Congressional 340B Action Unlikely in 2024, Say 340B Advocate, Drug Industry Analyst

Michael McCaughan, co-founder of Provision Policy, spoke about drug pricing policy at the 340B Coalition Winter Conference.
Congress is unlikely to act on 340B in 2024, but a potential flip of the U.S. Senate could lead to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tennessee Bills Introduced to Regulate 340B Funding for Certain STD Clinics

Companion bills recently introduced in the Tennessee state house and senate would add regulations for 340B in-kind funding.
Tennessee state lawmakers have introduced companion bills that would require sexually transmitted disease (STD) clinics to enter into a contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live